Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00741091 · ClinicalTrials.gov registry record · Phase 4
A Carotid Stenting Boston Scientific Surveillance Program
A Phase 4 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,097
- Enrollment target
NCT00741091 is a Phase 4 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,097 participants.
The verdict
NCT00741091, a Phase 4 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,097 participants
- Enrollment target
Study Summary
CABANA is a multicenter U.S. surveillance registry that will be conducted to compile early clinical outcomes data for the Carotid WALLSTENT Endoprosthesis and FilterWire EZ System in routine clinical practice and to assess the adequacy of the Boston Scientific Corporation (BSC) Carotid Stenting Training Program.
Interventions
- DEVICE Carotid WALLSTENT Monorail Endoprosthesis
- DEVICE FilterWire EZ™ System™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,097 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00741091
The ClinicalTrials.gov registry entry for NCT00741091 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,097 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Carotid WALLSTENT Monorail Endoprosthesis is the first listed.
NCT00741091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00741091 about?
NCT00741091 is a clinical study titled "A Carotid Stenting Boston Scientific Surveillance Program". CABANA is a multicenter U.S. surveillance registry that will be conducted to compile early clinical outcomes data for the Carotid WALLSTENT Endoprosthesis and FilterWire EZ System in routine clinical practice and to assess the adequacy of the Boston Scientific Corporation (BSC) Carotid Stenting Trai...
What is the current status of trial NCT00741091?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,097 participants. The study started on 2008-12. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00741091?
The interventions under investigation include: Carotid WALLSTENT Monorail Endoprosthesis (DEVICE), FilterWire EZ™ System™ (DEVICE).
Who is sponsoring clinical trial NCT00741091?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.